contraindications for glp-1 agonists include GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Glucagon-like Receptor-1 agonists for obesity:
Description
Frequently Asked Questions How does retatrutide work differently than semaglutide or tirzepatide
Arena R, Pronk NP, Lavie CJ
Recently, several multi-targeting agonists of GIPR, GLP-1R, or GCGR for treating T2DM and obesity have been in clinical trials
11 In clinical trials, exenatide has demonstrated efficacy in terms of both improved glycemic control and appetite suppression leading to weight loss
Steven S, Hausding M, Krller-Schn S, Mader M, Mikhed Y, Stamm P, et al
